Avanza Fonder Ab Moderna, Inc. Transaction History
Avanza Fonder Ab
- $3.37 Trillion
- Q4 2024
A detailed history of Avanza Fonder Ab transactions in Moderna, Inc. stock. As of the latest transaction made, Avanza Fonder Ab holds 33,504 shares of MRNA stock, worth $1.13 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
33,504Holding current value
$1.13 Million% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
943Shares Held
240MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$1.43 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.36 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$863 Million0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$569 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$244 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $13.2B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...